Cryoplateable Hepatocytes IDIQ
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- HT942626DE001_Redacted_Justification_and_approval
- Agency
-
Defense Health Agency
Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HT942526DE001 Federal IDV award
- Awardee
- Mabeal GMBH
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Westbury, New York 11590, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency, through the US Army Medical Research Acquisition Activity (USAMRAA), issued a sole-source Justification and Approval for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded to BioIVT, LLC on January 13, 2026, for the procurement of cryoplatable hepatocytes. The contract requires BioIVT to supply up to 250 units of Rhesus monkey or cynomolgus macaque cryoplatable hepatocytes annually, as well as up to 100 units of human cryoplatable hepatocytes, with the ordering period extending from December 18, 2025, through December 17, 2030. The sole-source justification is based on BioIVT's unique capability to provide certified cryoplatable hepatocytes specifically validated for the Plasmodium cynomolgi assay conducted at Walter Reed Army Institute of Research (WRAIR), which represents the only validated assay of its kind globally for anti-malarial activity testing. Market research conducted between February and May 2025, along with a Request for Information posted in July 2025, confirmed that no competing vendors possess the capability to provide hepatocytes meeting the required specifications, as alternative suppliers utilize unvalidated hepatocytes that would compromise assay effectiveness. While the specific contract value and funding type remain redacted, the award is structured as a firm-fixed-price contract following up on previous procurement W81XWH21D0004, and was established under the authority of 41 U.S.C. 1901 as implemented in FAR 13.501(a)(1)(ii) for commercial items.
Notice text
Posting of Redacted Justification and Approval
Awarded contract HT942526DE001 to unknown vendor for unknown amount on 2026-01-13.
Files
| File | Type | Posted |
|---|---|---|
| A02. JA FAR Part 13.5- Cryoplateable Hepatocytes IDIQ Redacted_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Cryoplateable Hepatocytes | Special Notice | |
| Cryoplateable Hepatocytes | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity